JP2020528758A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020528758A5 JP2020528758A5 JP2020505231A JP2020505231A JP2020528758A5 JP 2020528758 A5 JP2020528758 A5 JP 2020528758A5 JP 2020505231 A JP2020505231 A JP 2020505231A JP 2020505231 A JP2020505231 A JP 2020505231A JP 2020528758 A5 JP2020528758 A5 JP 2020528758A5
- Authority
- JP
- Japan
- Prior art keywords
- domain
- polypeptide chain
- functional
- antigen
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229920001184 polypeptide Polymers 0.000 claims 43
- 102000004196 processed proteins & peptides Human genes 0.000 claims 43
- 108090000765 processed proteins & peptides Proteins 0.000 claims 43
- 239000012634 fragment Substances 0.000 claims 30
- 239000000427 antigen Substances 0.000 claims 25
- 102000036639 antigens Human genes 0.000 claims 25
- 108091007433 antigens Proteins 0.000 claims 25
- 239000003446 ligand Substances 0.000 claims 8
- -1 ICOS Proteins 0.000 claims 7
- 125000003275 alpha amino acid group Chemical group 0.000 claims 6
- 108020003175 receptors Proteins 0.000 claims 6
- 102000005962 receptors Human genes 0.000 claims 6
- 102000039446 nucleic acids Human genes 0.000 claims 5
- 108020004707 nucleic acids Proteins 0.000 claims 5
- 150000007523 nucleic acids Chemical class 0.000 claims 5
- 102000004127 Cytokines Human genes 0.000 claims 4
- 108090000695 Cytokines Proteins 0.000 claims 4
- 210000004899 c-terminal region Anatomy 0.000 claims 4
- 102100026882 Alpha-synuclein Human genes 0.000 claims 3
- 102100029822 B- and T-lymphocyte attenuator Human genes 0.000 claims 3
- 102100021396 Cell surface glycoprotein CD200 receptor 1 Human genes 0.000 claims 3
- 102100039498 Cytotoxic T-lymphocyte protein 4 Human genes 0.000 claims 3
- 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 claims 3
- 102100034458 Hepatitis A virus cellular receptor 2 Human genes 0.000 claims 3
- 101710083479 Hepatitis A virus cellular receptor 2 homolog Proteins 0.000 claims 3
- 101000834898 Homo sapiens Alpha-synuclein Proteins 0.000 claims 3
- 101000864344 Homo sapiens B- and T-lymphocyte attenuator Proteins 0.000 claims 3
- 101000969553 Homo sapiens Cell surface glycoprotein CD200 receptor 1 Proteins 0.000 claims 3
- 101000889276 Homo sapiens Cytotoxic T-lymphocyte protein 4 Proteins 0.000 claims 3
- 101000945371 Homo sapiens Killer cell immunoglobulin-like receptor 2DL2 Proteins 0.000 claims 3
- 101000984186 Homo sapiens Leukocyte immunoglobulin-like receptor subfamily B member 4 Proteins 0.000 claims 3
- 101001138062 Homo sapiens Leukocyte-associated immunoglobulin-like receptor 1 Proteins 0.000 claims 3
- 101000611936 Homo sapiens Programmed cell death protein 1 Proteins 0.000 claims 3
- 101000652359 Homo sapiens Spermatogenesis-associated protein 2 Proteins 0.000 claims 3
- 101000831007 Homo sapiens T-cell immunoreceptor with Ig and ITIM domains Proteins 0.000 claims 3
- 101000914514 Homo sapiens T-cell-specific surface glycoprotein CD28 Proteins 0.000 claims 3
- 101000797332 Homo sapiens Trem-like transcript 2 protein Proteins 0.000 claims 3
- 102100033599 Killer cell immunoglobulin-like receptor 2DL2 Human genes 0.000 claims 3
- 102100025578 Leukocyte immunoglobulin-like receptor subfamily B member 4 Human genes 0.000 claims 3
- 102100020943 Leukocyte-associated immunoglobulin-like receptor 1 Human genes 0.000 claims 3
- 102000008115 Signaling Lymphocytic Activation Molecule Family Member 1 Human genes 0.000 claims 3
- 108010074687 Signaling Lymphocytic Activation Molecule Family Member 1 Proteins 0.000 claims 3
- 229940126547 T-cell immunoglobulin mucin-3 Drugs 0.000 claims 3
- 102100024834 T-cell immunoreceptor with Ig and ITIM domains Human genes 0.000 claims 3
- 102100027213 T-cell-specific surface glycoprotein CD28 Human genes 0.000 claims 3
- 102100032990 Trem-like transcript 2 protein Human genes 0.000 claims 3
- 210000004027 cell Anatomy 0.000 claims 3
- 102100032937 CD40 ligand Human genes 0.000 claims 2
- 102100025221 CD70 antigen Human genes 0.000 claims 2
- 102000004190 Enzymes Human genes 0.000 claims 2
- 108090000790 Enzymes Proteins 0.000 claims 2
- 102100039619 Granulocyte colony-stimulating factor Human genes 0.000 claims 2
- 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 claims 2
- 101000868215 Homo sapiens CD40 ligand Proteins 0.000 claims 2
- 101000934356 Homo sapiens CD70 antigen Proteins 0.000 claims 2
- 101000764535 Homo sapiens Lymphotoxin-alpha Proteins 0.000 claims 2
- 101000764294 Homo sapiens Lymphotoxin-beta Proteins 0.000 claims 2
- 101000638161 Homo sapiens Tumor necrosis factor ligand superfamily member 6 Proteins 0.000 claims 2
- 101000638255 Homo sapiens Tumor necrosis factor ligand superfamily member 8 Proteins 0.000 claims 2
- 102100037971 Interferon lambda receptor 1 Human genes 0.000 claims 2
- 108010074328 Interferon-gamma Proteins 0.000 claims 2
- 108010050904 Interferons Proteins 0.000 claims 2
- 102000014150 Interferons Human genes 0.000 claims 2
- 108010002350 Interleukin-2 Proteins 0.000 claims 2
- 108010002386 Interleukin-3 Proteins 0.000 claims 2
- 108090000978 Interleukin-4 Proteins 0.000 claims 2
- 108010002616 Interleukin-5 Proteins 0.000 claims 2
- 108090001005 Interleukin-6 Proteins 0.000 claims 2
- 102100026238 Lymphotoxin-alpha Human genes 0.000 claims 2
- 102100026894 Lymphotoxin-beta Human genes 0.000 claims 2
- 102100031789 Myeloid-derived growth factor Human genes 0.000 claims 2
- 102100029740 Poliovirus receptor Human genes 0.000 claims 2
- 108060008682 Tumor Necrosis Factor Proteins 0.000 claims 2
- 102100024568 Tumor necrosis factor ligand superfamily member 11 Human genes 0.000 claims 2
- 102100024584 Tumor necrosis factor ligand superfamily member 12 Human genes 0.000 claims 2
- 102100026890 Tumor necrosis factor ligand superfamily member 4 Human genes 0.000 claims 2
- 102100031988 Tumor necrosis factor ligand superfamily member 6 Human genes 0.000 claims 2
- 102100032100 Tumor necrosis factor ligand superfamily member 8 Human genes 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 108010048507 poliovirus receptor Proteins 0.000 claims 2
- 108010011170 Ala-Trp-Arg-His-Pro-Gln-Phe-Gly-Gly Proteins 0.000 claims 1
- 102000016605 B-Cell Activating Factor Human genes 0.000 claims 1
- 108010028006 B-Cell Activating Factor Proteins 0.000 claims 1
- 102100038080 B-cell receptor CD22 Human genes 0.000 claims 1
- 102100024222 B-lymphocyte antigen CD19 Human genes 0.000 claims 1
- 108010074708 B7-H1 Antigen Proteins 0.000 claims 1
- 102100026189 Beta-galactosidase Human genes 0.000 claims 1
- 102000001902 CC Chemokines Human genes 0.000 claims 1
- 108010040471 CC Chemokines Proteins 0.000 claims 1
- 102100036008 CD48 antigen Human genes 0.000 claims 1
- 108091011896 CSF1 Proteins 0.000 claims 1
- 108010078239 Chemokine CX3CL1 Proteins 0.000 claims 1
- 102100035298 Cytokine SCM-1 beta Human genes 0.000 claims 1
- 102100020997 Fractalkine Human genes 0.000 claims 1
- 102100031351 Galectin-9 Human genes 0.000 claims 1
- 101710121810 Galectin-9 Proteins 0.000 claims 1
- 108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 claims 1
- 101000884305 Homo sapiens B-cell receptor CD22 Proteins 0.000 claims 1
- 101000980825 Homo sapiens B-lymphocyte antigen CD19 Proteins 0.000 claims 1
- 101000716130 Homo sapiens CD48 antigen Proteins 0.000 claims 1
- 101000804771 Homo sapiens Cytokine SCM-1 beta Proteins 0.000 claims 1
- 101000746367 Homo sapiens Granulocyte colony-stimulating factor Proteins 0.000 claims 1
- 101000746373 Homo sapiens Granulocyte-macrophage colony-stimulating factor Proteins 0.000 claims 1
- 101001019455 Homo sapiens ICOS ligand Proteins 0.000 claims 1
- 101000599613 Homo sapiens Interferon lambda receptor 1 Proteins 0.000 claims 1
- 101001002470 Homo sapiens Interferon lambda-1 Proteins 0.000 claims 1
- 101000853002 Homo sapiens Interleukin-25 Proteins 0.000 claims 1
- 101000853000 Homo sapiens Interleukin-26 Proteins 0.000 claims 1
- 101000998139 Homo sapiens Interleukin-32 Proteins 0.000 claims 1
- 101000804764 Homo sapiens Lymphotactin Proteins 0.000 claims 1
- 101000934338 Homo sapiens Myeloid cell surface antigen CD33 Proteins 0.000 claims 1
- 101001128431 Homo sapiens Myeloid-derived growth factor Proteins 0.000 claims 1
- 101000741544 Homo sapiens Properdin Proteins 0.000 claims 1
- 101000914484 Homo sapiens T-lymphocyte activation antigen CD80 Proteins 0.000 claims 1
- 101000611183 Homo sapiens Tumor necrosis factor Proteins 0.000 claims 1
- 101000830603 Homo sapiens Tumor necrosis factor ligand superfamily member 11 Proteins 0.000 claims 1
- 101000830598 Homo sapiens Tumor necrosis factor ligand superfamily member 12 Proteins 0.000 claims 1
- 101000830600 Homo sapiens Tumor necrosis factor ligand superfamily member 13 Proteins 0.000 claims 1
- 101000830596 Homo sapiens Tumor necrosis factor ligand superfamily member 15 Proteins 0.000 claims 1
- 101000597779 Homo sapiens Tumor necrosis factor ligand superfamily member 18 Proteins 0.000 claims 1
- 101000764263 Homo sapiens Tumor necrosis factor ligand superfamily member 4 Proteins 0.000 claims 1
- 102100034980 ICOS ligand Human genes 0.000 claims 1
- 102100026720 Interferon beta Human genes 0.000 claims 1
- 102100026688 Interferon epsilon Human genes 0.000 claims 1
- 101710147309 Interferon epsilon Proteins 0.000 claims 1
- 102100037850 Interferon gamma Human genes 0.000 claims 1
- 102100022469 Interferon kappa Human genes 0.000 claims 1
- 101710145151 Interferon lambda receptor 1 Proteins 0.000 claims 1
- 102100020990 Interferon lambda-1 Human genes 0.000 claims 1
- 108010047761 Interferon-alpha Proteins 0.000 claims 1
- 102000006992 Interferon-alpha Human genes 0.000 claims 1
- 108090000467 Interferon-beta Proteins 0.000 claims 1
- 102000008070 Interferon-gamma Human genes 0.000 claims 1
- 108010002352 Interleukin-1 Proteins 0.000 claims 1
- 102000000589 Interleukin-1 Human genes 0.000 claims 1
- 108090000174 Interleukin-10 Proteins 0.000 claims 1
- 102000003814 Interleukin-10 Human genes 0.000 claims 1
- 102100020788 Interleukin-10 receptor subunit beta Human genes 0.000 claims 1
- 101710199214 Interleukin-10 receptor subunit beta Proteins 0.000 claims 1
- 108090000177 Interleukin-11 Proteins 0.000 claims 1
- 108010065805 Interleukin-12 Proteins 0.000 claims 1
- 108090000176 Interleukin-13 Proteins 0.000 claims 1
- 108090000172 Interleukin-15 Proteins 0.000 claims 1
- 101800003050 Interleukin-16 Proteins 0.000 claims 1
- 102000013691 Interleukin-17 Human genes 0.000 claims 1
- 108050003558 Interleukin-17 Proteins 0.000 claims 1
- 108090000171 Interleukin-18 Proteins 0.000 claims 1
- 102100039879 Interleukin-19 Human genes 0.000 claims 1
- 108050009288 Interleukin-19 Proteins 0.000 claims 1
- 102100030703 Interleukin-22 Human genes 0.000 claims 1
- 102000013264 Interleukin-23 Human genes 0.000 claims 1
- 108010065637 Interleukin-23 Proteins 0.000 claims 1
- 102100036679 Interleukin-26 Human genes 0.000 claims 1
- 108010066979 Interleukin-27 Proteins 0.000 claims 1
- 101710181613 Interleukin-31 Proteins 0.000 claims 1
- 102100033501 Interleukin-32 Human genes 0.000 claims 1
- 108010067003 Interleukin-33 Proteins 0.000 claims 1
- 101710181549 Interleukin-34 Proteins 0.000 claims 1
- 108091007973 Interleukin-36 Proteins 0.000 claims 1
- 108010002586 Interleukin-7 Proteins 0.000 claims 1
- 108090001007 Interleukin-8 Proteins 0.000 claims 1
- 108010002335 Interleukin-9 Proteins 0.000 claims 1
- 108060001084 Luciferase Proteins 0.000 claims 1
- 239000005089 Luciferase Substances 0.000 claims 1
- 102100035304 Lymphotactin Human genes 0.000 claims 1
- 102100028123 Macrophage colony-stimulating factor 1 Human genes 0.000 claims 1
- 101100407308 Mus musculus Pdcd1lg2 gene Proteins 0.000 claims 1
- 102100025243 Myeloid cell surface antigen CD33 Human genes 0.000 claims 1
- 102100037589 OX-2 membrane glycoprotein Human genes 0.000 claims 1
- 101710187081 OX-2 membrane glycoprotein Proteins 0.000 claims 1
- 108010042215 OX40 Ligand Proteins 0.000 claims 1
- 102000003992 Peroxidases Human genes 0.000 claims 1
- 102000004211 Platelet factor 4 Human genes 0.000 claims 1
- 108090000778 Platelet factor 4 Proteins 0.000 claims 1
- 108700030875 Programmed Cell Death 1 Ligand 2 Proteins 0.000 claims 1
- 102100024216 Programmed cell death 1 ligand 1 Human genes 0.000 claims 1
- 102100024213 Programmed cell death 1 ligand 2 Human genes 0.000 claims 1
- 108010025832 RANK Ligand Proteins 0.000 claims 1
- 108091079435 SIS family Proteins 0.000 claims 1
- 102100027222 T-lymphocyte activation antigen CD80 Human genes 0.000 claims 1
- 108010065158 Tumor Necrosis Factor Ligand Superfamily Member 14 Proteins 0.000 claims 1
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 claims 1
- 102100040247 Tumor necrosis factor Human genes 0.000 claims 1
- 101710097155 Tumor necrosis factor ligand superfamily member 12 Proteins 0.000 claims 1
- 102100024585 Tumor necrosis factor ligand superfamily member 13 Human genes 0.000 claims 1
- 102100024586 Tumor necrosis factor ligand superfamily member 14 Human genes 0.000 claims 1
- 102100024587 Tumor necrosis factor ligand superfamily member 15 Human genes 0.000 claims 1
- 102100035283 Tumor necrosis factor ligand superfamily member 18 Human genes 0.000 claims 1
- 108010005774 beta-Galactosidase Proteins 0.000 claims 1
- 230000003197 catalytic effect Effects 0.000 claims 1
- 238000004587 chromatography analysis Methods 0.000 claims 1
- 230000021615 conjugation Effects 0.000 claims 1
- 239000002872 contrast media Substances 0.000 claims 1
- FOCAHLGSDWHSAH-UHFFFAOYSA-N difluoromethanethione Chemical compound FC(F)=S FOCAHLGSDWHSAH-UHFFFAOYSA-N 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 229940079322 interferon Drugs 0.000 claims 1
- 229960003130 interferon gamma Drugs 0.000 claims 1
- 108010080375 interferon kappa Proteins 0.000 claims 1
- 229940047124 interferons Drugs 0.000 claims 1
- 108090000681 interleukin 20 Proteins 0.000 claims 1
- 108010074109 interleukin-22 Proteins 0.000 claims 1
- 102000003898 interleukin-24 Human genes 0.000 claims 1
- 108090000237 interleukin-24 Proteins 0.000 claims 1
- 210000002540 macrophage Anatomy 0.000 claims 1
- OHDXDNUPVVYWOV-UHFFFAOYSA-N n-methyl-1-(2-naphthalen-1-ylsulfanylphenyl)methanamine Chemical compound CNCC1=CC=CC=C1SC1=CC=CC2=CC=CC=C12 OHDXDNUPVVYWOV-UHFFFAOYSA-N 0.000 claims 1
- 108040007629 peroxidase activity proteins Proteins 0.000 claims 1
- 102000040430 polynucleotide Human genes 0.000 claims 1
- 108091033319 polynucleotide Proteins 0.000 claims 1
- 239000002157 polynucleotide Substances 0.000 claims 1
- 230000007928 solubilization Effects 0.000 claims 1
- 238000005063 solubilization Methods 0.000 claims 1
- 102000003390 tumor necrosis factor Human genes 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023097920A JP2023123588A (ja) | 2017-07-31 | 2023-06-14 | 可変ドメインと定常ドメインとの間のエルボー領域に機能的ドメインを有する抗体 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EPPCT/EP2017/069357 | 2017-07-31 | ||
| PCT/EP2017/069357 WO2019024979A1 (en) | 2017-07-31 | 2017-07-31 | FUNCTIONAL DOMAIN ANTIBODIES IN THE ELBOW REGION |
| PCT/EP2018/070640 WO2019025391A1 (en) | 2017-07-31 | 2018-07-30 | ANTIBODIES HAVING FUNCTIONAL DOMAINS IN THE ELBOW REGION BETWEEN A VARIABLE DOMAIN AND A CONSTANT DOMAIN |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023097920A Division JP2023123588A (ja) | 2017-07-31 | 2023-06-14 | 可変ドメインと定常ドメインとの間のエルボー領域に機能的ドメインを有する抗体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020528758A JP2020528758A (ja) | 2020-10-01 |
| JP2020528758A5 true JP2020528758A5 (cg-RX-API-DMAC10.html) | 2021-09-09 |
| JP7297734B2 JP7297734B2 (ja) | 2023-06-26 |
Family
ID=59626578
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020505231A Active JP7297734B2 (ja) | 2017-07-31 | 2018-07-30 | 可変ドメインと定常ドメインとの間のエルボー領域に機能的ドメインを有する抗体 |
| JP2023097920A Withdrawn JP2023123588A (ja) | 2017-07-31 | 2023-06-14 | 可変ドメインと定常ドメインとの間のエルボー領域に機能的ドメインを有する抗体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023097920A Withdrawn JP2023123588A (ja) | 2017-07-31 | 2023-06-14 | 可変ドメインと定常ドメインとの間のエルボー領域に機能的ドメインを有する抗体 |
Country Status (13)
Families Citing this family (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018231827A1 (en) | 2017-06-12 | 2018-12-20 | Bluefin Biomedicine, Inc. | Anti-il1rap antibodies and antibody drug conjugates |
| CN120463807A (zh) | 2018-03-22 | 2025-08-12 | 表面肿瘤学有限责任公司 | 抗il-27抗体及其用途 |
| CN112313333A (zh) * | 2018-05-10 | 2021-02-02 | 秘来生物制剂株式会社 | 包含抗体的抗原结合区、融合生理活性肽的人工蛋白质 |
| CN112384627A (zh) | 2018-05-30 | 2021-02-19 | 生物医学研究所 | 通过利用内源激活诱导性胞嘧啶脱氨酶改造b淋巴细胞 |
| CN113811549A (zh) | 2019-02-21 | 2021-12-17 | Xencor股份有限公司 | 非靶向和靶向性il-10 fc融合蛋白 |
| US20250263466A1 (en) | 2020-02-03 | 2025-08-21 | Vir Biotechnology, Inc. | Antibodies against sars-cov-2 and methods of using the same |
| HUE062777T2 (hu) | 2020-02-26 | 2023-12-28 | Vir Biotechnology Inc | SARS-CoV-2 elleni antitestek |
| WO2021203053A1 (en) | 2020-04-03 | 2021-10-07 | Vir Biotechnology, Inc. | Immunotherapy targeting a conserved region in sars coronaviruses |
| BR112022020706A2 (pt) | 2020-04-14 | 2022-11-29 | Vir Biotechnology Inc | Anticorpos contra sars-cov-2 e métodos de uso dos mesmos |
| PH12022500020A1 (en) | 2020-05-08 | 2024-05-06 | Vir Biotechnology Inc | Antibodies against sars-cov-2 |
| WO2021247925A1 (en) | 2020-06-03 | 2021-12-09 | Vir Biotechnology, Inc. | Structure-guided immunotherapy against sars-cov-2 |
| EP4165077A1 (en) | 2020-06-12 | 2023-04-19 | VIR Biotechnology, Inc. | Antibody therapies for sars-cov-2 infection |
| BR112023005684A2 (pt) | 2020-09-28 | 2023-11-07 | Humabs Biomed Sa | Anticorpos contra sars-cov-2 |
| CN113214394B (zh) * | 2020-10-30 | 2023-01-06 | 上海洛启生物医药技术有限公司 | 抗il5纳米抗体及其应用 |
| CA3199429A1 (en) | 2020-11-23 | 2022-05-27 | Davide Corti | Anti-influenza antibodies and combinations thereof |
| PH12023551390A1 (en) | 2020-11-23 | 2023-12-04 | Humabs Biomed Sa | Broadly neutralizing antibodies against influenza neuraminidase |
| KR20230135569A (ko) | 2020-11-23 | 2023-09-25 | 비르 바이오테크놀로지, 인코포레이티드 | 인플루엔자 a 바이러스에 대한 항체 |
| JP2023550785A (ja) | 2020-11-25 | 2023-12-05 | ヴィア・バイオテクノロジー・インコーポレイテッド | 複数のベータコロナウイルスに結合する抗体 |
| TW202241935A (zh) * | 2020-12-18 | 2022-11-01 | 美商世紀治療股份有限公司 | 具有可調適受體專一性之嵌合抗原受體系統 |
| CN117916272A (zh) * | 2020-12-30 | 2024-04-19 | 上海药明生物技术有限公司 | 多特异性抗原结合蛋白 |
| CN112877394A (zh) * | 2021-01-27 | 2021-06-01 | 南京大学 | B7-h4+单核细胞型mdsc在制备ins激素治疗疗效预测试剂中的应用 |
| CN117136197A (zh) * | 2021-02-09 | 2023-11-28 | 胡默波斯生物医学公司 | 抗呼吸道合胞病毒、人偏肺病毒和小鼠肺炎病毒的抗体和其使用方法 |
| WO2022204202A1 (en) | 2021-03-23 | 2022-09-29 | Vir Biotechnology, Inc. | Antibodies that bind to multiple sarbecoviruses |
| KR20240004680A (ko) * | 2021-05-07 | 2024-01-11 | 센티 바이오사이언시스, 인코포레이티드 | 키메라 수용체 및 이의 사용 방법 |
| KR20240035758A (ko) | 2021-05-24 | 2024-03-18 | 비르 바이오테크놀로지, 인코포레이티드 | 조작된 폴리펩타이드 |
| WO2023034871A1 (en) | 2021-09-01 | 2023-03-09 | Vir Biotechnology, Inc. | High concentration antibody therapies for sars-cov-2 infection |
| JP2024533166A (ja) | 2021-09-01 | 2024-09-12 | ヴィア・バイオテクノロジー・インコーポレイテッド | 小児被験体におけるＳＡＲＳ－ＣｏＶ－２感染の抗体療法 |
| CN114934065A (zh) * | 2021-11-25 | 2022-08-23 | 浙江理工大学绍兴生物医药研究院有限公司 | 携带免疫检查点分子tim-3抗体基因的溶瘤腺病毒构建方法和应用 |
| CA3240483A1 (en) | 2021-12-10 | 2023-06-15 | Thomas Dudler | Therapeutic antibodies that bind to the serine protease domain of masp-2 and uses thereof |
| EP4489782A4 (en) | 2022-03-10 | 2026-03-25 | Omeros Corp | MASP-2 and MASP-3 inhibitors, and associated compositions and methods for the treatment of sickle cell disease |
| WO2023201256A1 (en) | 2022-04-12 | 2023-10-19 | Vir Biotechnology, Inc. | High dose antibody therapies for sars-cov-2 infection |
| WO2023230448A1 (en) | 2022-05-23 | 2023-11-30 | Vir Biotechnology, Inc. | Combination immunotherapy for influenza |
| US20260184814A1 (en) | 2022-05-23 | 2026-07-02 | Humabs Biomed Sa | Broadly neutralizing antibodies against influenza neuraminidase |
| WO2023245078A1 (en) | 2022-06-15 | 2023-12-21 | Humabs Biomed Sa | Anti-parvovirus antibodies and uses thereof |
| WO2024006472A1 (en) | 2022-06-30 | 2024-01-04 | Vir Biotechnology, Inc. | Antibodies that bind to multiple sarbecoviruses |
| JP2025526405A (ja) | 2022-07-27 | 2025-08-13 | ヒューマブス・バイオメッド・ソシエテ・アノニム | Ｒｓｖ及びｍｐｖパラミクソウイルスに対する広域中和抗体 |
| WO2024112818A1 (en) | 2022-11-22 | 2024-05-30 | Humabs Biomed Sa | Engineered anti-sars-cov-2 antibodies and uses thereof |
| WO2024118998A2 (en) | 2022-12-01 | 2024-06-06 | Vir Biotechnology, Inc. | Engineered anti-sars-cov-2 antibodies and methods of using the same |
| TW202446788A (zh) | 2023-04-10 | 2024-12-01 | 美商維爾生物科技公司 | 結合多種薩貝冠狀病毒之抗體 |
| WO2025010424A1 (en) | 2023-07-06 | 2025-01-09 | Vir Biotechnology, Inc. | Antibodies against staphylococcus antigens and methods of using the same |
| EP4743488A1 (en) | 2023-07-13 | 2026-05-20 | VIR Biotechnology, Inc. | Antibodies widely neutralizing against paramyxoviruses RSV and MPV |
| WO2026030503A2 (en) * | 2024-07-30 | 2026-02-05 | Invisishield Technologies Ltd. | Compositions and methods for preventing the spread of viruses |
| WO2026039642A1 (en) | 2024-08-16 | 2026-02-19 | Ardeagen Corporation | Anti-mesothelin antibody conjugates and methods of use thereof |
| WO2026055183A1 (en) | 2024-09-03 | 2026-03-12 | Vir Biotechnology, Inc | Antiviral compositions and methods of using the same |
| WO2026117540A1 (en) | 2024-11-27 | 2026-06-04 | Vir Biotechnology, Inc. | Anti-hiv-1 antibodies and uses thereof |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2001270609A1 (en) * | 2000-06-30 | 2002-01-14 | Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw | Heterodimeric fusion proteins |
| WO2004076677A2 (en) | 2003-02-26 | 2004-09-10 | Institute For Research In Biomedicine | Monoclonal antibody production by ebv transformation of b cells |
| US7700097B2 (en) | 2003-06-27 | 2010-04-20 | Biogen Idec Ma Inc. | Purification and preferential synthesis of binding molecules |
| MX2009012343A (es) | 2007-05-14 | 2010-02-10 | Biogen Idec Inc | Regiones fc (sc fc) de cadena sencilla, polipeptidos de enlace que comprenden las mismas, y metodos relacionados con ello. |
| CN101952312A (zh) * | 2007-07-31 | 2011-01-19 | 米迪缪尼有限公司 | 多特异性表位结合蛋白及其应用 |
| ES2525346T3 (es) | 2008-10-22 | 2014-12-22 | Institute For Research In Biomedicine | Métodos para producir anticuerpos a partir de células plasmáticas |
| US20120195900A1 (en) * | 2010-12-22 | 2012-08-02 | Abbott Laboratories | Tri-variable domain binding proteins and uses thereof |
| US20140235476A1 (en) * | 2012-12-28 | 2014-08-21 | Abbvie, Inc. | Multivalent binding protein compositions and methods for identifying variants of same |
| EP2938637A2 (en) * | 2012-12-28 | 2015-11-04 | AbbVie Inc. | Multivalent binding protein compositions |
| EP2927227A4 (en) | 2013-01-03 | 2015-12-30 | Celltrion Inc | ANTIBODY CONCENTRATOR REMEDY CONJUGATE, METHOD OF MANUFACTURING THEREOF, AND ANTIBODY TOGETHER THEREWITH |
| CN107531784B (zh) * | 2015-04-29 | 2021-08-27 | 生物医学研究所 | 通过多特异性抗体超强力地中和细胞因子和其用途 |
| RU2730671C2 (ru) * | 2015-06-18 | 2020-08-24 | Виб Взв | Иммуноглобулин с одним вариабельным доменом против f-белка pcb |
| CA2990785C (en) | 2015-06-24 | 2024-11-12 | Jcr Pharmaceuticals Co., Ltd. | ANTI-HUMAN TRANSFERRIN RECEPTOR ANTIBODIES CROSSING THE BLOOD-BRAIN BARRIER |
| WO2016207402A1 (en) | 2015-06-26 | 2016-12-29 | Institute For Research In Biomedicine | Proteins comprising a mutated lair-1 fragment and uses thereof |
| EP3387013B1 (en) * | 2015-12-07 | 2022-06-08 | Xencor, Inc. | Heterodimeric antibodies that bind cd3 and psma |
| CN112313333A (zh) * | 2018-05-10 | 2021-02-02 | 秘来生物制剂株式会社 | 包含抗体的抗原结合区、融合生理活性肽的人工蛋白质 |
-
2017
- 2017-07-31 WO PCT/EP2017/069357 patent/WO2019024979A1/en not_active Ceased
-
2018
- 2018-07-30 KR KR1020207006050A patent/KR20200032738A/ko active Pending
- 2018-07-30 EA EA202090364A patent/EA202090364A1/ru unknown
- 2018-07-30 MX MX2020001080A patent/MX2020001080A/es unknown
- 2018-07-30 CN CN201880048796.4A patent/CN111094341A/zh active Pending
- 2018-07-30 BR BR112019028180-0A patent/BR112019028180A2/pt not_active Application Discontinuation
- 2018-07-30 US US16/635,506 patent/US12331108B2/en active Active
- 2018-07-30 EP EP18752697.5A patent/EP3661962A1/en active Pending
- 2018-07-30 JP JP2020505231A patent/JP7297734B2/ja active Active
- 2018-07-30 AU AU2018311032A patent/AU2018311032B2/en active Active
- 2018-07-30 CA CA3069265A patent/CA3069265A1/en active Pending
- 2018-07-30 SG SG11201911658QA patent/SG11201911658QA/en unknown
- 2018-07-30 WO PCT/EP2018/070640 patent/WO2019025391A1/en not_active Ceased
-
2020
- 2020-01-28 IL IL272303A patent/IL272303A/en unknown
-
2023
- 2023-06-14 JP JP2023097920A patent/JP2023123588A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Chmielewski et al. | TRUCKs: the fourth generation of CARs | |
| CN113260368B (zh) | 抗gpc3嵌合抗原受体(car)与反式共刺激分子的组合及其治疗用途 | |
| Geering et al. | Synthetic immunology: modulating the human immune system | |
| JP2019502379A5 (cg-RX-API-DMAC10.html) | ||
| TWI809130B (zh) | 嵌合跨膜蛋白及其用途 | |
| CN110913871B (zh) | 生成哺乳动物t细胞活化诱导型合成启动子(syn+pro)以改善t细胞疗法 | |
| JP6449143B2 (ja) | 二重特異性を有する融合タンパク質産生のための共有結合したホモ二量体化モジュールとしてのＩｇＭおよびＩｇＥ重鎖ドメイン２ | |
| JP2024521405A5 (cg-RX-API-DMAC10.html) | ||
| JP2019088330A5 (cg-RX-API-DMAC10.html) | ||
| TWI811212B (zh) | 嵌合多肽及改變其膜定位之方法 | |
| JP2018514199A5 (cg-RX-API-DMAC10.html) | ||
| JP2018529327A5 (cg-RX-API-DMAC10.html) | ||
| Aung et al. | Recent and future perspectives on engineering interferons and other cytokines as therapeutics | |
| RU2009100153A (ru) | Одноцепочечные мультивалентные связывающие белки с эффекторной функцией | |
| JP2020528758A (ja) | 可変ドメインと定常ドメインとの間のエルボー領域に機能的ドメインを有する抗体 | |
| RU2749113C2 (ru) | Содержащая рнк композиция для лечения опухолевых заболеваний | |
| AU2018277294A1 (en) | Oncolytic virus and method | |
| Huang et al. | Targeting IFN-α to B cell lymphoma by a tumor-specific antibody elicits potent antitumor activities | |
| EP3768700A1 (en) | Chimeric transmembrane proteins and uses thereof | |
| JP2018521959A5 (cg-RX-API-DMAC10.html) | ||
| WO2020028572A2 (en) | ANTIBODY-COUPLED T CELL RECEPTORS (ACTRs) IN COMBINATION WITH TRANS CO-STIMULATORY MOLECULES AND THERAPEUTIC USES THEREOF | |
| WO2024123793A2 (en) | Macrophage-specific promoters and uses thereof | |
| WO2021156277A1 (en) | Immune cell expressing adapter chimeric antigen receptor for sensing soluble antigens | |
| JP2025500918A5 (cg-RX-API-DMAC10.html) | ||
| JPWO2023204290A5 (cg-RX-API-DMAC10.html) |